These 3 Top Healthcare Stocks Are Screaming Buys Right Now
Signs that the stock market is expensive are all around us. For one, Warren Buffett's favorite indicator -- the ratio of total market capitalization of the stock market to gross domestic product -- is at an all-time high. At 239%, it's higher than it was the before the dot-com crash of 2001 and the global financial crisis in 2008. Those are the last two times it eclipsed 100%.
For a conservative choice, we asked three contributors to Fool.com to recommend a healthcare company that looked cheap in this expensive market. They chose CRISPR Therapeutics (NASDAQ: CRSP), Bristol Myers Squibb (NYSE: BMY), and Fulgent Genetics (NASDAQ: FLGT). Here's why.
Image source: Getty Images.
Source Fool.com
